#

Eli Lilly

: 82
The transaction gives Eli Lilly access to AtaiBeckley’s experimental drug being studied in phase III clinical trials for treatment-resistant depression / Photo: Shutterstock.com / Tada Images
Small Caps·
+1
·
Eli Lilly officially to acquire psychedelics drugmaker AtaiBeckley for $3.8 bln
BlackRock warned clients against investing in Chinese indices / Photo: John Hanson Pye/Shutterstock.com
News·
BlackRock advised investors to focus on specific AI stocks in China rather than the entire region
Eli Lillys new obesity drug led to weight loss by more than a quarter / Photo: Jonathan Weiss / Shutterstock.com
News·
'Eli Lilly pulls ahead': investors praise new obesity drug
Growing revenues from weight management products allow Eli Lilly to actively increase investments and develop new directions. Photo: Jonathan Weiss / Shutterstock.com
Review·
Defeating dementia: where Eli Lilly is investing $4 billion
Eli Lilly will buy three vaccine developers. Photo: ChrisStock82/Shutterstock
News·
Eli Lilly will invest nearly $4 billion to buy three vaccine developers. Why would she do that?
Photo: X/NYSE
News·
Morning in New York: the situation is favorable for buying
Eli Lilly grew profits by 168% and raised its full-year forecast / Photo: Tada Images / Shutterstock
News·
Eli Lilly grew earnings 168% and raised its full-year guidance. What's up with the stock?
Eli Lilly to buy cancer drug developer Kelonia / Photo: Jonathan Weiss / Shutterstock.com
News·
Eli Lilly to buy oncology drug developer. What is it paying up to $7 billion for?
Prospects for a second round of Iran-US peace talks remain uncertain / Photo: somkanae sawatdinak / Shutterstock.com
News·
Morning in New York: Investors focus on escalation in the Middle East
The UAE is discussing with the US financial support in case of a prolonged conflict with Iran, WSJ has learned / Photo: Wael Hneini / unsplash
Review·
Highlights for the morning: UAE to ask for help, US intercepts Iranian ship, oil surges
Kailera Therapeutics Inc. has raised $625 million in an upsized IPO, marking the sector’s biggest U.S. listing since 2021 / Photo: Kailera
News·
+1
·
Kailera Therapeutics IPO: Shares of obesity drugmaker start trading
Novo Nordisk intends to implement OpenAI AI tools in all business processes by the end of 2026 / Photo: Below the Sky/Shutterstock.com
News·
"Superpower Charge": Novo Nordisk bets on OpenAI in confrontation with Eli Lilly
Load more